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Pulmonary function testing remains the gold standard for the diagnosis and management of wheezing disorders
in older children and adults. Although wheezing disorders are among the most common clinical problems in
pediatrics, most young children and toddlers cannot perform most of the currently clinically available pulmo-
nary function tests. In this article, we review the different types of pulmonary function tests available and
discuss the applicability and utility in the different age groups with specific reference to suitability in the
diagnosis and management of wheezing disorders.
Introduction
Asthma is a chronic reversible obstructive airway dis-ease. In school-age children objective measurement of
lung function is essential to the diagnosis and evaluation of
asthma, as medical history and physical examination are not
reliable means of assessment.1 Although clinicians are gen-
erally able to identify airflow obstruction clinically,2 they are
unable to assess the degree or reversibility of the airflow
obstruction.3 In a recent study, up to a third of children with
moderate-to-severe asthma were reclassified to a more se-
vere asthma category when spirometry was assessed in ad-
dition to symptom frequency.4 In contrast, another study
found that most children with mild-to-moderate asthma by
symptom classification were found to have normal lung
function by FEV1 [forced expiratory volume in one second
(spirometry)].5 These seemingly contradictory findings em-
phasize the importance of including pulmonary function
testing (PFT) in a comprehensive assessment of asthma.
Recurrent wheezing affects 20%–30% of infants and tod-
dlers, yet resolves in at least half of these children by school
age. Eighty percent of school-age children with persistent
asthma were symptomatic by age 6 years, with more than
half symptomatic by age 3 years.6 However, differentiating
transient wheezing from persistent asthma in the early years
is problematic since the 2 syndromes have only been de-
scribed epidemiologically. Therefore, practical methodolo-
gies to objectively assess lung function in infants and
toddlers for the purposes of accurately diagnosing asthma
are highly desirable.
In this review, we will attempt to concisely review the
literature of currently available pulmonary function tech-
niques in children to assist in the diagnosis and management
of asthma and recurrent wheezing.
Spirometry
Childhood
Spirometry is the gold standard for the diagnosis and
management of asthma. It is themost commonly usedmethod
to assess lung function. Recent NIH guidelines7 recommend
the use of spirometry, specifically FEV1 and FEV1/FVC
[forced vital capacity (spirometry)] ratio for the diagnosis and
management of children older than 5 years. This is in part due
to the fact that pulmonary function has been found to be more
sensitive than clinical examination2,3 or symptoms for the
detection of obstructive pathology.4 The greatest value in di-
agnosing asthma with the use of spirometry is the docu-
mentation of reversibility with short acting bronchial agonist.
The degree of reversibility has been correlatedwith the degree
of airway inflammation8 and postbronchodilator measures
can be used to follow lung growth and remodeling.9 Further,
those children with the greatest reversibility with a short
acting bronchial agonist are most at risk for remodeling and
loss of lung function over time.10
Other factors making spirometry a useful test in the as-
sessment of asthma and bronchodilator response (BDR) in-
clude portability of the measurement device, ease of use for
the operator, and repeatability of the maneuver. Spirometry
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is the least variable of the pulmonary function maneuvers
currently commercially offered in most clinical laboratories.
The coefficient of variation for FEV1 ranges from 2.7% to 5%,
whereas the variability of other measures such as specific
airway resistance (sRaw), respiratory resistance during in-
terruption (interrupter resistance) (Rint), and respiratory
impedance (forced oscillation technique) (Xrs) are at least
double to triple.11,12 This low coefficient of variation would
suggest that FEV1 would be the most sensitive test to detect
BDR; however, most studies have not assessed the between-
occasion repeatability in disease states.13 Only 1 study in
adults studied this phenomenon and suggested that the
variability of FEV1 was significantly higher in disease states,
thus suggesting that other measures may be more sensitive
to BDR assessment.13 This conclusion requires further study.
Other limitations of FEV1 relate to the physiology under-
lying its measurement. Asthma is primarily a disease of the
small airways14 and studies in well-controlled asthmatics
have shown continued obstruction and airway inflammation
in the small airways despite normal measures of the large
airways. The FEV1 may remain preserved despite significant
small airway obstruction, and hence the need for more sen-
sitive measures of small airway obstruction. This is an active
area of research and may in the near future lead to the de-
velopment of novel strategies to monitor disease progression.
At the current time, FEV1 remains the most studied lung
function measure in asthma and remains the most re-
commended physiological assessment for the diagnosis and
management of wheezing disorders in childhood.
Preschool children
Children as young as 3 years of age are capable of per-
forming spirometry under ideal laboratory conditions when
trained by technicians skilled in performing spirometry in
this age group. In 2007 the American Thoracic Society (ATS)
and European Respiratory Society (ERS) published a state-
ment that included technical recommendations for the per-
formance of spirometry in preschool children to facilitate
comparison of data between centers.11 Several studies de-
scribing spirometric data in healthy preschool-age children
have been published over the past decade,15–18 and recently
Stanojevic et al. published robust reference equations for
children ages 3 through 7 years based on an analysis of
preschool lung function data from 3,777 children collated
from 15 centers in 11 countries.19
An important limitation to clinical use of preschool spi-
rometry is the lack of repeatability data, thus limiting inter-
pretations of change in lung function following a clinical
intervention, such as response to bronchodilators or corti-
costeroids. Another practical limitation is the feasibility of
obtaining measurements in a busy clinical practice. Recently,
Gaffin et al. conducted a real-world assessment of preschool
spirometry feasibility in 248 children in a busy pediatric
pulmonary function laboratory.20 In their hands, 82% of
preschool children performing spirometry for the first time
were able to complete at least 1 technically acceptable ma-
neuver, but only 54% were capable of performing spirometry
that was acceptable and repeatable based on ATS/ERS pre-
school spirometry recommendations. Although, the group of
children with asthma reported in the cohort by Gaffin et al.,
did not have forced expiratory volumes or flows that were
significantly different from healthy children; 30% of the in-
dividual asthmatic children had evidence of airflow ob-
struction by FEV1 or FEF25–75 [forced expiratory flow at 25%
to 75% of expiration (spirometry)], suggesting that preschool
spirometry may provide clinically useful information for a
substantial subset of individual patients in this age group.
Infants
Although infants and toddlers are not capable of inde-
pendently performing spirometric maneuvers, the raised-
volume rapid thoracoabdominal compression (RVRTC)
technique can be used to measure forced expiratory flows and
volumes in children £ 3 years of age under sedation with
chloral hydrate. During the RVRTC maneuver an infant’s
lungs are inflated to near total lung capacity (TLC) followed by
a forced expiration.21–23 The RVRTC technique allows gener-
ation of flow–volume curves that are similar to adult-type
flow–volume curves. RVRTC-forced expiratory flows and
volumes have been used to assess infants with bronchiolitis
and recurrent wheezing,24,25 and bronchodilator responsive-
ness in healthy infants.26 Reference values fromhealthy infants
are published,27 and 2 devices to perform infant PFT (iPFT)
using the RVRTC method are commercially available.
However, there are several important barriers to using the
RVRTC technique to obtain lung function measurements
for clinical use. Little data exist regarding the within- and
between-occasion repeatability of RVRTC measurements.
Performing RVRTC measurements is complex and time con-
suming, requires sedation of the patient, and must be per-
formed using expensive equipment operated by highly
trained personnel. For these reasons, the ability to obtain high-
quality RVRTCmeasurements is limited to a small number of
laboratories around the world. Published normative data
were derived from a relatively small sample size (n = 155),
limiting its generalizability to populations around the world
with different ethnicities as well as social and environmental
backgrounds.27 Further, longitudinal studies assessing the
predictive value of RVRTC lung function values for per-
sistent asthma among infants with recurrent wheezing is
lacking. Although published data describing forced ex-
piratory volumes and flows following administration of al-
buterol in healthy children exist,26 a consensus does not yet
reached on the definition of a clinical BDR during RVRTC
maneuvers. Although infant lung function testing using the
RVRTC technique is a powerful research tool, the technical
issues summarized above may limit its use as a routine clin-
ical tool in assessing infants and toddlers with wheezing
disorders.
Lung Volume Measurements
Plethysmography
Lung volume measurements in preschool and school-age
children are easily performed using multiple methodologies,
including whole-body plethysmography or gas washout
techniques. Plethysmographic measurements can be per-
formed using either panting methods (only suitable for older
children) or single inspiratory effort technique.28 However,
there are conflicting reports on the utility of lung volume
parameters in children with controlled asthma.29,30 This may
be due in part to the selection of proper reference data and
high variability in measurement of some of the parameters.
The literature suggests that in older individuals, static lung
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volume measurement may be abnormal in asthmatic patients
and more sensitive than FEV1 to small airway dysfunc-
tion.31,32 This methodology has been hampered by the need
for bulky expensive equipment, lack of portability, and dif-
ficulty in performing the maneuver.
Whole-body plethysmography can be performed in infants
and toddlers using commercially available equipment to obtain
measurements of functional residual capacity (plethysmo-
graphy) (FRCpleth), residual volume (RV), TLC, and the ratio of
RV/TLC.33 However, there is very little published data asses-
sing the utility of plethysmographic lung function measures in
infants and toddlerswith recurrentwheezing to predict asthma.
Saito et al. reported that among children less than 3 years old
with recurrent wheezing unresponsive to asthma medications,
plethysmography revealed mean FRC and RV/TLC measure-
ments greater than 2 z-scores above published normative
data.34 Unfortunately, the only available published normative
plethysmography data35 are based on a very small sample size,
limiting generalizability of plethysmography measurements in
the assessment of infants and toddlerswith recurrentwheezing.
Multiple breath inert gas washout
The multiple breath inert gas washout technique is used
to assess lung ventilation inhomogeneity as well as mea-
surement of FRC. The advantage of multiple breath washout
is that it is an effort independent technique and thus can be
applied from infancy to adulthood using tidal breathing
techniques.11,36 The lung clearance index (LCI), the cumula-
tive expired volume required to clear the inert gas to 1/40th
of the initial gas concentration from the lungs divided by the
FRC, seems to be a useful and sensitive measure of periph-
eral airway obstruction, especially in cystic fibrosis.37–41
Other parameters can also be calculated such as the normal-
ized slopes and moment ratios. The usefulness of these other
parameters is limited by the small number of studies and the
increasing complexity in understanding what they represent
physiologically. The ideal parameter for reporting is elusive at
present due to the paucity of data in the different age ranges
and disease entities. Several studies have been published
suggesting that LCI, moment ratios, as well as other param-
eters are significantly different in patients suffering from
asthma and preschool wheeze.42–46 One study has suggested
that its utility may be superior to other pulmonary func-
tion parameters that are possible to perform in preschool
children.47 However, further work needs to be done to un-
derstand the relevance of abnormalities in LCI and whether
it correlates to clinically meaningful outcomes longi-
tudinally. The multiple breath washout methodology is cur-
rently available using different commercial devices; however,
validation studies comparing different methodologies are
lacking and standardization in reporting has not been estab-
lished.
Airway Resistance Measurements
Specific airway resistance
Plethysmographic measurements of sRaw can be ob-
tained during tidal breathing without the need for special-
ized breathing maneuvers or respiration against an airway
occlusion.48 sRaw is calculated as the product of FRC and
Raw.49 This technique has been successfully performed in
children as young as age 2 years.50 While limited data from a
few specialized research centers suggest that sRaw is in-
creased in preschool-age children with recurrent wheezing or
asthma compared to healthy children,51–56 it has been pur-
ported in older subjects to be more sensitive to bronchodi-
lator changes than traditional lung function tests such as
spirometry.13,57 Further, sRaw has been demonstrated to
improve following treatment with inhaled corticosteroids,54
leukotriene receptor antagonists,51 and b2-agonists.
55,58
Despite the appeal of sRaw as a lung functionmeasurement
that can be obtained in preschool-age children, there are a
number of important limitations to the applicability of this
measure in clinical decision making in preschool-age children.
A consensus does not exist with regard to standardization of
measurement equipment and conditions, and data analysis.
Recently, as part of The Asthma UK Initiative, Kirkby et al.
proposed reference equations constructed from sRaw data
obtained from healthy children ages 3–10 years at 5 European
centers.59 However, Kirkby et al. caution that their reference
equations should only be applied to populations studied using
the same methodology as employed in the centers included in
their analysis. The development of international consensus
recommendations (eg, ATS/ERS) for equipment and method-
ology to perform sRaw measurements in preschool-age chil-
drenwould facilitate its utility as a lung functionmeasurement
technique for clinical use in the diagnosis or monitoring of
asthma or wheezing disorders in this age group.
The interrupter technique
Respiratory tract resistance can be estimated during tidal
breathing using the interrupter technique. Based on the as-
sumption that during a brief airway occlusionmouth pressure
rapidly equilibrates with alveolar pressure, respiratory Rint is
defined as occlusion mouth pressure divided by the airflow
measured immediately before an occlusion.60 Measurement
of Rint using commercially available equipment is possible in
most children as young as 3 years old with acceptable within-
and between-occasion repeatability.11 Using data collected
from more than 1,000 children, Merkus et al. recently pub-
lished robust reference equations to allow better interpreta-
tion of Rint measurements obtained from young children.61
Several clinical studies have demonstrated higher Rint values
among preschool-age children with asthma or recurrent
wheezing as compared to healthy controls; however, a large
degree of overlap in distribution of Rint between healthy and
asthmatic or wheezy infants has been noted.55,62,63
Although Rint has been used to estimate the magnitude of
change in airflow resistance in response to a bronchodilator,
an accepted cut-off to define bronchodilator responsiveness in
preschool-age children does not currently exist.11 Due to the
poor discriminative power of Rint between asthma and health
at the individual level, and lack of a defined clinical BDR, the
utility of Rint in clinical diagnosis of asthma in preschool-age
children is limited. However, with the advent of newly es-
tablished reference equations,61 Rint may prove to be useful
to assess response to therapeutic interventions longitudinally.
Forced oscillometry
The forced oscillation technique (FOT) is a noninvasive
lung function test that can be performed during tidal
breathing with minimal cooperation from the patient.64 Gi-
ven the simplicity of the maneuver, the FOT technique is an
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attractive methodology for use in preschool-age children.
Unfortunately, the complexity of the mathematic and physics
assumptions upon which FOT is based have proven chal-
lenging for clinicians and researchers alike to fully under-
stand. Several reviews are available for a more complete
description of the underlying principal of FOT.11,64–66 Briefly,
an oscillatory signal, most commonly pseudorandom at fre-
quencies between 4 and 10Hz, is applied to the airway
opening using a mouthpiece. Flow and pressure are mea-
sured at the mouth. Resultant pressure and flow fluctuations
at the mouth in response to the applied oscillatory signal are
measured. The pressure and flow relationship is described as
Xrs, where Xrs is determined by the elastic and inertial
properties of the respiratory system. Respiratory resistance
(Rrs) represents the total Rrs, of which airway resistance is
the most significant.
A recent ATS/ERS statement on PFT in preschool chil-
dren attempted to standardize FOT measurements by re-
commending that the optimal measurement frequencies be
between 4 and 8Hz.11 For preschool-age children mean co-
efficient of variation (CV%) and between-test coefficient of
repeatability (CR%) for Rrs between 4 and 8Hz are reported
between 6% and 10%.67–70 A number of published studies
have proposed reference equations for FOT Rrs based on
measurements in healthy children.68–76 Unfortunately, these
reference equations do not use a standard frequency and
there is significant variability between studies in equipment
and measurement protocols.
Some studies of preschool-age children have reported
both greater Xrs and Rrs at one or more frequencies among
children with asthma or wheezing, some studies have re-
ported higher Rrs, yet no difference in Xrs in asthmatic or
wheezy subjects, whereas other investigators report no dif-
ferences in either Xrs or Rrs between asthmatic/wheezy
subjects and healthy controls.55,68,77,78 There is very little
longitudinal FOT data in preschool-age children to assess the
diagnostic utility of FOT in predicting asthma in young
children with recurrent wheezing. Although several studies
have proposed criteria to identify bronchodilator respon-
siveness in preschool-age children, proposed frequency and
cutoff values vary significantly between studies.55,67,70,77,79–81
Measurements of Airway Inflammation
Exhaled nitric oxide
The fractional concentration of exhaled nitric oxide
(FENO) is a proposed biomarker of airway inflammation in
asthma.82 FENO has repeatedly been shown to be elevated in
adults and children with allergic asthma83 and rhinitis84 but
has been minimally studied in infants and toddlers. In adults
and school-age children with atopic asthma FENO is corre-
lated with sputum and bronchoalveolar eosinophils, peak
flow variability, and bronchial reactivity.85–92 FENO de-
creases following treatment with systemic or inhaled corti-
costeroids in adults and school-age children with asthma,93
and has been shown to have a superior diagnostic accuracy
for asthma than conventional diagnostic approaches, in-
cluding spirometry.85,94–96 Several groups have demon-
strated in cross-sectional studies that FENO is higher in
wheezy infants and toddlers than in healthy controls97–101;
however, FENO was measured during tidal breathing in all
but one of these studies. In a longitudinal study of preschool
children (mean enrollment age > 3 years) elevated tidal
breathing FENO was associated with a 3-fold higher risk of
respiratory illness over 1 year of follow-up.102 Major limita-
tions of tidal breathing FENO measurement in infants/tod-
dlers include nasal nitric oxide contamination because nasal
nitric oxide production far exceeds lower airway production
and widely variable expiratory flow because FENO mea-
surement is highly flow dependent.103,104 Recently, Debley
et al. demonstrated in a longitudinal study of wheezy in-
fants/toddlers that higher enrollment flow-regulated single-
breath exhaled nitric oxide levels were associated with a
subsequent decline in lung function, increased risk of sub-
sequent treatment with systemic corticosteroids for wheez-
ing exacerbations, and bronchodilator responsiveness.105
Further, enrollment single-breath exhaled nitric oxide was
superior to lung function and bronchodilator responsiveness
as a predictor of wheezing exacerbations during follow-up.
Despite its promise as a potential diagnostic test for asthma
in infants and preschool-age children, due to the lack of a
standardized approach to measurement in this age group
and paucity of longitudinal data, FENO is not yet a suitable
clinical tool for use in infants and preschool-age children.
Exhaled breath condensate
Analysis of constituents of exhaled breath may in the
future prove useful to noninvasively evaluate the biology of
lung or airway diseases. However, even in school-age chil-
dren and adults the measurement of biomarkers in exhaled
breath condensates (EBC) is an immature field with many
unresolved methodological challenges.106 Although a variety
of volatile and nonvolatile compounds have been detected in
EBC by many investigators, there is a dearth of data re-
garding the physiological factors that affect EBC composi-
tion.84,107 A recent ATS/ERS Task Force report identified the
need for studies that assess accuracy and reproducibility of
EBC collection and analysis before the widespread intro-
duction of EBC into clinical trials or practice.107 Although
there are reports of successful breath condensate collection
and subsequent measurement of inflammatory mediators
within EBC collected from infants and preschool-age chil-
dren,108–111 technical barriers to successful collection of ade-
quate volumes of EBC to allow for assays of potential
biomarkers are even more significant in this age range.
Summary
For school-age children measurement of lung function
using spirometry is an indispensible component of the di-
agnostic approach to asthma and longitudinal monitoring of
asthma control. Spirometry provides objective clinical data
that are complimentary to an accurate medical history and
physical examination for many children with asthma or re-
current wheezing.
A number of additional lung function testing modalities,
including RVRTC iPFTs, preschool spirometry, the LCI,
specific airway resistance, and forced oscillometry, have
shown significant promise in research studies as potential
tools for the assessment of infants, toddlers, and preschool-
age children with recurrent wheezing. In our opinion, given
the availability of commercial devices and published reference
equations, preschool spirometry may be clinically useful in
identifying airflow obstruction in individual children when
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performed by providers with appropriate expertise and ex-
perience. While limited in its ability to distinguish health
from disease at the level of the individual, validation studies
and reference equations are also sufficient to consider clinical
measurement of airflow resistance with Rint to track re-
sponse to therapeutic interventions longitudinally. At the
present time, a lack adequate validation studies, reference
data, or commercial devices, and technical complexity limit
the clinical utility of RVRTC iPFTs, the LCI, specific airway
resistance, and forced oscillometry in the routine assessment
of preschool-age children with recurrent wheezing. Finally,
there has been great interest in the measurement of FENO to
assess lower airway inflammation in patients with asthma.
Based on several recent randomized controlled trials, there is
insufficient data to support its routine use to titrate inhaled
corticosteroids in children with asthma. However, given that
FENO is easy to measure in school-age children, it can be
measured with clinically approved devices, and sufficient
data exist establishing its diagnostic utility in steroid naı¨ve
patients, FENO can be recommended as an adjunctive diag-
nostic tool in children in whom the diagnosis of asthma is
unclear despite standard clinical measures.
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